OnCoCross Co Ltd
KOSDAQ:382150
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OnCoCross Co Ltd
KOSDAQ:382150
|
KR |
|
I
|
IMBiologics Corp
KOSDAQ:493280
|
KR |
|
P
|
Petroleo Brasileiro SA Petrobras
SWB:PJXA
|
BR |
|
H
|
Horng Tong Enterprise Co Ltd
TPEX:5271
|
TW |
|
Ellaktor SA
OTC:ELLKF
|
GR |
|
Petroleo Brasileiro SA Petrobras
NYSE:PBR
|
BR |
|
C
|
CU Medical Systems Inc
KOSDAQ:115480
|
KR |
|
Satyamitra Kemas Lestari Tbk PT
IDX:SMKL
|
ID |
|
S
|
Samik Pharm Co Ltd
KOSDAQ:014950
|
KR |
|
JMDC Inc
TSE:4483
|
JP |
|
S
|
Sbc Corporation Bhd
KLSE:SBCCORP
|
MY |
|
Slavneft' Megionneftegaz P.A.O.
MOEX:MFGSP
|
RU |
|
Casio Computer Co Ltd
TSE:6952
|
JP |
|
Anglesey Mining PLC
LSE:AYM
|
UK |
|
G
|
Gudang Garam Tbk PT
XMUN:GGG
|
ID |
Bankruptcy Probability
OnCoCross Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
OnCoCross Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
O
|
OnCoCross Co Ltd
KOSDAQ:382150
|
45.7B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
471.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
217.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
74.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
OnCoCross Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, OnCoCross Co Ltd has total debt of 8.2B KRW. This includes both short-term (0 KRW) and long-term (8.2B KRW) debt.
You can find a full breakdown on its Balance Sheet.